To access a recap of this past event, please Click HERE.
Friends of Cancer Research Congressional Briefing
Safeguarding the Public Health: Enhancing Information About Prescription Drugs
Hart Senate Office Building
Washington, DC, 20002
Tuesday, March 20, 2018
2:00 PM – 3:30 PM EDT
Patients, caregivers and their physicians and nurses need high quality sources of information about the prescription drugs they use. While many sources of information exist, none can deliver as strong assurances of reliability and scientific accuracy as FDA-approved product labels. Labels are the most carefully-vetted sources of prescribing information available today and play a critical role in safeguarding the public health.
Despite the critical role labels can play in promoting informed treatment decisions, a new study by Friends of Cancer Research (Friends) shows that most cancer drug labels are considerably out of date.
Friends is convening a briefing on Capitol Hill to examine the role of prescription drug labeling in our healthcare system.
• Participants will discuss reasons why labels fall out of date and the current obstacles preventing drug manufacturers from maintaining up-to-date prescribing information.
• A group including patient advocates, FDA leadership, and expert clinicians will discuss the impact of outdated labels on the healthcare system, including how obsolete prescribing information can threaten the public health and jeopardize reimbursement for needed medications.
- Janet Woodcock, U.S. Food and Drug Administration
- Jeff Allen, Friends of Cancer Research
- Angela Green, Memorial Sloan Kettering Cancer Center
- Josephine Torrente, Hyman, Phelps & McNamara, PC
- Angus Worthing, American College of Rheumatology
- Moderator: Kate Rawson, Prevision Policy